Table 2.
Week | Bupropion SR + CM (n = 37) | Bupropion SR + Non-CM (n = 36) | Placebo + CM (n = 29) | Placebo + Non-CM (n = 32) |
---|---|---|---|---|
3† | 14 (37.8) | 7 (19.4) | 3 (10.3) | 3 (9.4) |
4 | 14 (37.8) | 6 (16.7) | 3 (10.3) | 5 (15.6) |
5 | 11 (29.7) | 5 (13.9) | 3 (10.3) | 3 (9.4) |
6 (End of Treatment) | 10 (27.0) | 3 (8.3) | 3 (10.3) | 3 (9.4) |
12 (Follow-Up) | 4 (10.8) | 2 (5.6) | 0 (0.0) | 2 (6.3) |
following initial 2-week grace period